PDS Biotechnology Corporation Insider Trading
PDSB
No open-market buying or selling by insiders.
The last open-market buy by an executive or director was in Feb 2025.
Get an email when PDSB's executives or directors buy, or make a large sale outside a plan.
Trades · last 2 years
| Date | Insider | Trade | Shares | Price | Value | Of their stake | Filing |
|---|---|---|---|---|---|---|---|
| Feb 28, 2025 | Gregory Gene Freitag Director | Bought | 15,060 | $1.66 | 25K | 33% | Form 4 |
| Feb 28, 2025 | Stephen C. Glover Director | Bought | 15,061 | $1.66 | 25K | 24% | Form 4 |
- Feb 28, 2025Gregory Gene FreitagDirector · bought 15,060 at $1.6625K33% of stake
- Feb 28, 2025Stephen C. GloverDirector · bought 15,061 at $1.6625K24% of stake
Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.
Peers
Pharmaceutical Preparations · Pick stocks to compare with PDSB
Held by ETFs
PDSB is in 1 US ETF. The largest of them, with PDSB's weight in each:
Spot a number that looks wrong? Check it in PDSB's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing PDSB
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.